Searchable abstracts of presentations at key conferences in endocrinology

ea0056p864 | Pituitary - Clinical | ECE2018

An immunohistochemical study on pituitary adenomas

Burcea Iulia Florentina , Capatina Cristina , Poiana Catalina

Introduction: Pituitary adenomas (PA) represent approximately 15% of all intracranial neoplasms, with a global incidence of 15,20 per million per year. The immunohistochemical analysis of PA is necessary for diagnosis and plays an important role in the modern classification system of pituitary tumors.Material and methods: Samples from 142 surgically resected PA were studied immunohistochemically using antisera for 6 anterior pituitary hormones. Reticulin...

ea0099ep984 | Calcium and Bone | ECE2024

Recurrent hyperparathyroidism after total parathyroidectomy with autotransplantation in a patient with long-term hemodialysis

Serban Cristina , Baculescu Nicoleta , Poiana Catalina

Background: Recurrenthyperparathyroidism following total parathyroidectomy with autotransplantation in patients with end-stage renal disease who are on hemodialysis is not an uncommon condition and can be due to hyperplastic autografted tissue, remnant parathyroid tissues in the neck or in the presence of ectopic and/or supernumerary parathyroid glands.Case report: We report the case of a 66-year-old patient with a history of chronic kidney disease on he...

ea0081p227 | Thyroid | ECE2022

Thyrotoxicosis-associated anemia at baseline and after methimazole treatment

Naglabeala Laura , Alexandru Niculescu Dan , Vladescu Anda , Poiana Catalina

Background: Overt newly diagnosed hyperthyroidism is frequently associated with mild anemia. However, there are limited data on long term evolution under methimazole treatment. Our aim was to study the baseline characteristics and evolution of anemia in the hyperthyroidism setting.Methods: We retrospectively assessed 58 consecutive patients [46 (79.3%) women] presenting with newly diagnosed overt thyrotoxicosis (43 Graves disease, 9 toxic nodular goiters...

ea0081ep729 | Pituitary and Neuroendocrinology | ECE2022

Case report: a challenging gastrinoma in a patient with renal cell carcinoma

Ioana Paduraru Alina , Burcea Iulia Florentina , Poiana Catalina

Introduction: Gastrinomas are rare neuroendocrine tumours (NETs) that arise from enterochromaffin-like cells and produce gastrin. Most are discovered in the duodenum and pancreas. The clear cell type of renal cell carcinoma (RCC) is known for the expression of gastrin-releasing peptide receptor (GRP-R) and some studies have shown GRP can stimulate tumor cell proliferation and neoangiogenesis. Therefore, we present a case with metachronous development of renal cell carcinoma an...

ea0086p254 | Neuroendocrinology and Pituitary | SFEBES2022

Prevalence of cancer in a cohort of acromegaly patients

Trifanescu Raluca , Toma Iustin , Dumitrascu Anda , Goldstein Andrei , Poiana Catalina

Background: Growth hormone directly stimulates tumour growth, angiogenesis and metastasis through autocrine and paracrine effects on cancer cells, while through IGF1 inhibits apoptosis and promotes epithelial proliferation. Although disputed, some studies have shown an increased cancer incidence in acromegaly patients, especially in uncontrolled subjects, while others have not.Aim: To assess prevalence of cancer in a cohort of patients with long term tre...

ea0086p259 | Neuroendocrinology and Pituitary | SFEBES2022

Successful use of recombinant human TSH prior to radioiodine therapy in an acromegaly patient with differentiated thyroid cancer and pituitary insufficiency

Toma Iustin , Trifanescu Raluca , Goldstein Andrei , Dumitrascu Anda , Poiana Catalina

Background: Differentiated thyroid cancer (DTC) is the most common endocrine malignancy. Standard treatment includes thyroidectomy (extention depending on tumour size, pathology and lymph nodes involvement). If indicated, radioiodine therapy after TSH stimulation either by levothyroxine withdrawal or rhTSH administration is recommended. In patients with thyrotropin deficiency rhTSH administration is mandatory.Case report: A 30-year-old woman, resident in...

ea0090p3 | Adrenal and Cardiovascular Endocrinology | ECE2023

Late onset congenital adrenal hyperplasia after the fifth decade of life: case series

Zaifu Laura , Dusceac Roxana , Naglabeala Laura , Niculescu Dan , Poiana Catalina

Introduction: Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder that is caused by mutations of genes involved with adrenal steroidogenesis. The mutations mostly occur in the 21-hydroxylase gene and rarely in the 3β-hydroxysteroid dehydrogenase gene or 11β-hydroxylase genes. Our aim is to present a series of 3 cases of patients with late onset CAH, probably due to 21-hydroxylase deficiency, after 50 years of age.Case series...

ea0090p126 | Endocrine-related Cancer | ECE2023

Carcinoembryonic antigen role in the assessment of neuroendocrine tumors

Dobre Ramona , Florentina Burcea Iulia , Capatana Cristina , Poiana Catalina

Background: The importance of carcinoembryonic antigen (CEA) assessment in the evaluation of medullary thyroid carcinoma is well known. The role of CEA in the assessment of other neuroendocrine tumors (NET) is not clear. We aimed to evaluate a possible correlation between CEA measurements and the aggressivity of NETs.Methods: We evaluated 56 (36 women) NETs followed in a tertiary center (23 gastrointestinal, 12 pancreatic, 10 pulmonary, 7 without primary...

ea0090ep101 | Adrenal and Cardiovascular Endocrinology | ECE2023

Aggravation of depressive symptoms after biochemical cure of Cushing syndrome

Arbunea-Ghenoiu Sandra , Piser Alexandra , Capatina Cristina , Poiana Catalina

Introduction: Endogenous Cushing syndrome (CS), is associated with significant morbidity (metabolic, cardiovascular, bone, psychiatric complications among others). Most complications tend to improve if hypercortisolism is controlled but some are only partially reversible or even experience temporary exacerbation.Patients and Methods: We report 2 cases of adrenal Cushing Syndrome (CS). The first is a 72 years-old female with CS caused by bilateral macrono...

ea0090ep742 | Pituitary and Neuroendocrinology | ECE2023

Hyponatremia apparently due to carbamazepine as the initial presentation of panhypopituitarism in a patient with a non-functioning pituitary tumour

Vladan Andreea , Iancu Cristina , Radian Serban , Poiana Catalina

Introduction: Hyponatremia, defined as a serum sodium concentration below 135 mEq/l, has a heterogeneous etiology, the main endocrine causes includind the syndrome of inappropiate antidiuresis (SIAD), adrenal insufficiency and severe hypothyroidism.Materials and methods: Clinical, hormonal and imaging evaluationAim: To present a case of hyponatremia leading to the diagnosis of a large pituitary tumorCase pres...